Clinical binding properties, internalization kinetics, and clinicopathologic activity of brentuximab vedotin: an antibody-drug conjugate for CD30-positive lymphoid neoplasms.
Clin Lymphoma Myeloma Leuk., Aug;12(4):280-3 (2012)
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.
Blood., May;119(18):4115-22 (2012)
Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia.
Br. J. Haematol., Oct;155(2):182-9 (2011)
Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation.
J. Clin. Oncol., Aug;29(22):3023-9 (2011)
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.
Biol. Blood Marrow Transplant., Oct;17(10):1537-45 (2011)
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.
J. Clin. Oncol., Mar;29(9):1182-9 (2011)
Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.
Leuk. Lymphoma., Aug;51(8):1523-9 (2010)
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas.
Br. J. Haematol., Jul;150(2):170-8 (2010)
Does high-dose therapy and autologous hematopoietic stem cell transplantation have a role in the primary treatment of peripheral T-cell lymphomas? ASH evidence-based review 2008.
Hematology Am Soc Hematol Educ Program., 39-41 (2008)
Evidence-based guidelines--an introduction.
Hematology Am Soc Hematol Educ Program., 26-30 (2008)
T-cell lymphoma: one name with a dozen faces.
Leuk. Lymphoma., Nov;49(11):2033-4 (2008)